Embera Neurotherapeutics, Inc.
Pharmaceutical company · Sudbury, Massachusetts, United States
Embera Neurotherapeutics, Inc. is a pharmaceutical company headquartered in Sudbury, Massachusetts, United States. Its earliest recorded incorporation is in 2005. It has reported private securities offerings to the US SEC, most recently $6.1 million sold in a notice filed in 2019.
Embera Neurotherapeutics at a glance
What does Embera Neurotherapeutics do?
Private fundraising reported to the SEC
9 Form D notices; the most recent reported $6.1 million sold (2019).
Frequently asked questions about Embera Neurotherapeutics
Where is Embera Neurotherapeutics headquartered?
Embera Neurotherapeutics, Inc. is headquartered in Sudbury, Massachusetts, United States.
What does Embera Neurotherapeutics do?
Embera Neurotherapeutics, Inc. is a pharmaceutical company.
When was Embera Neurotherapeutics founded?
The earliest incorporation on record for Embera Neurotherapeutics, Inc. is in 2005, according to public company registers.
Similar companies
- AbbVie Inc.North Chicago, Illinois, United States
- Savara IncAustin, Texas, United States
- Crinetics Pharmaceuticals, Inc.San Diego, California, United States
- Cartesian Therapeutics, Inc.Frederick, Maryland, United States
- Karyopharm Therapeutics Inc.Newton, Massachusetts, United States
- Dare Bioscience, Inc.San Diego, California, United States
- Cellectar Biosciences, Inc.Florham Park, New Jersey, United States
- Marker Therapeutics, Inc.Houston, Texas, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences